We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Solvay Settles Estratest False Marketing Suit For $16M

Law360 (March 18, 2010, 3:38 PM EDT) -- A federal judge has granted final approval to a $16.5 million class action settlement that will end a lawsuit accusing Solvay Pharmaceuticals Inc. of falsely marketing menopause-treating drugs as if they...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.